Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRB1 | P17538 | 2/20 | 0.53 |
| ▸ | ELANE | P08246 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | NAMPT | P43490 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6717299 | 0.93 | CTRB1 (0.54) | CTRB1ELANECYP3A4L3MBTL1KMT2A | |
| SCHEMBL6635374 | 0.91 | ELANE (0.54) | CTRB1ELANECYP3A4KMT2APOLB | |
| SCHEMBL6635955 | 0.86 | ELANE (0.56) | CTRB1ELANEKMT2AHPGDALDH1A1 | |
| SCHEMBL6636762 | 0.86 | ELANE (0.51) | CTRB1ELANECYP3A4NAMPT | |
| SCHEMBL6636103 | 0.86 | CTRB1 (0.57) | CTRB1ELANECYP3A4L3MBTL1LMNA | |
| SCHEMBL6638769 | 0.84 | ELANE (0.55) | CTRB1ELANECYP3A4KMT2APOLB | |
| SCHEMBL6635224 | 0.82 | CTRB1 (0.59) | CTRB1ELANECYP3A4KMT2ALMNA | |
| SCHEMBL6639790 | 0.82 | CTRB1 (0.59) | CTRB1ELANECYP3A4L3MBTL1LMNA | |
| SCHEMBL6635970 | 0.80 | CTRB1 (0.49) | CTRB1ELANECYP3A4LMNANAMPT | |
| SCHEMBL6641671 | 0.79 | ELANE (0.52) | CTRB1ELANECYP3A4NAMPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040116420-A1 | Remedial agent for viral infectious disease | ASAHI KASEI PHARMA CORPORATION (JP) | 2004-06-17 | — | — | US | disclosed |
| EP-1403269-A1 | REMEDIAL AGENT FOR VIRAL INFECTIOUS DISEASE | Asahi Kasei Pharma Corporation (JP) | 2004-03-31 | — | — | EP | disclosed |